Double-blind multicenter clinical trial on the efficacy of phosphocreatinine vs L-carnitine and placebo in a group of patients affected by heart disease
Are overweight or obese (have a high BMI) Are, or have been, a smoker Don't do much exercise or lead a sedentary lifestyle Drink alcohol regularly or are a binge drinker Have an underactive thyroid gland (hypothyroidism) Have diabetes, or impaired glucose tolerance Have family history of heart disease Have immediate family who have had a heart attack, stroke or heart bypass surgery Have kidney disease Have polycystic ovary syndrome Want To Monitor GLP-1 Treatment Order your GLP-1 Essential Wellness test and get the insights you need to feel your best
These lifestyle shifts do more than just maintain weight loss they enhance overall well-being
The project involved researchers from Aarhus University's Department of Biomedicine, the Department of Molecular Medicine (MOMA) at Aarhus University Hospital, the Clinic for Rheumatic and Connective Tissue Diseases at the Medical Diagnostic Centre at Hospitalsenhed Midt, the Novo Nordisk Foundation Center for Basic Metabolic Research, and the Department of Biomedical Sciences at the University of Copenhagen
ad-hoc dose splitting is not
